Maxim Sokolovskiy

Dr. Maxim Sokolovskiy

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2025 in Russian Journal of Forensic Medicine
Verified
Journal Article
Closed access
PDF file
GMGulgena R. Mustafina
Gulgena R. Mustafina
KKKirill O. Kuznetsov
Kirill O. Kuznetsov
SKSvetlana A. Kosobutskaya
Svetlana A. Kosobutskaya
MSMaxim Sokolovskiy
Maxim Sokolovskiy
ASAlvina I. Semenova
Alvina I. Semenova
VKValeriy N. Korotun
Valeriy N. Korotun
Determination of the postmortem interval remains one of the key tasks in forensic practice, as the accuracy of this assessment directly affects the objectivity of expert conclusions and the effectiveness of investigative procedures. Traditional postmortem interval estimation methods based on morphological indicators and thermometry have limited reliability, especially in the late postmortem period. Current research focuses on developing innovative approaches employing molecular technologies, microbiome analysis, multiomic strategies, and the integration of artificial intelligence for large-scale data processing. This review summarizes modern methods for estimating the postmortem interval, including nucleic acid (DNA and RNA) analysis, proteomic and metabolomic approaches, and the study of microbiome changes. Particular attention is given to immunohistochemical markers, mass spectrometry, and nuclear magnetic resonance for quantification of biochemical processes in tissues and biological fluids. The prospects of applying molecular and chemical methods in forensic entomology during the late postmortem period are highlighted. A separate section discusses the use of machine and deep learning algorithms to construct predictive models based on multimodal data, including microbiome profiles, imaging features, and environmental parameters. Examples of combined approaches integrating biomolecular markers and computational technologies are presented, enabling more accurate estimation of the postmortem interval during both early and late postmortem periods.

1 August 2026 in Viruses
Verified
Journal Article
Open access
PDF file
KTKonstantin Sergeevich Troshin
Konstantin Sergeevich Troshin
LILydia I. Ilyenko
Lydia I. Ilyenko
ACAndrei Viktorovich Chaplin
Andrei Viktorovich Chaplin
AKAnastasiya A. Khritova
Anastasiya A. Khritova
GSGeorge Skvortsov
George Skvortsov
Peter V. EvseevPeter V. Evseev
Peter V. Evseev
Enterococcus faecalis is an important opportunistic pathogen associated with persistent oral infections, biofilm formation, and antimicrobial tolerance, which makes phages targeting this species of both therapeutic and evolutionary interest. Here, we describe the isolation and characterization of Abitsa, a novel lytic Enterococcus phage representing a new species within the genus Efquatrovirus. Abitsa formed small plaques and displayed siphovirus-like morphology. It showed an optimal multiplicity of infection of 0.01, a short latent period of 10 min and a burst size of 28 ± 5 virions per infected cell. The phage efficiently suppressed planktonic growth of E. faecalis over a broad multiplicity of infection (MOI) range and significantly disrupted pre-formed biofilms, with the strongest effect observed at MOI 0.1, resulting in an 82.14% reduction in biofilm biomass. Abitsa remained stable at pH 4–8, at 5–50 °C for 1 h, and in up to 75% chloroform, but exhibited a narrow host range, lysing only one additional clinical E. faecalis isolate among 34 tested enterococcal isolates. Genome analysis showed that Abitsa has a 41,581-bp linear genome lacking lysogeny-associated genes and represents a novel Efquatrovirus species. Comparative structural and phylogenetic analyses additionally supported mosaic evolution and extensive domain shuffling in receptor-binding and lysis-related proteins of Efquatrovirus-like phages. Together, these results identify Abitsa as a biologically unusual and evolutionarily informative lytic phage with antibiofilm activity.

6 August 2025 in Urology Reports (St. - Petersburg)
Verified
Journal Article
Closed access
PDF file
SSSabir Sh. Sabirzyanov
Sabir Sh. Sabirzyanov
MSMaxim Sokolovskiy
Maxim Sokolovskiy
EKEkaterina V. Kozhevnikova
Ekaterina V. Kozhevnikova
MKMarat S. Khaydarov
Marat S. Khaydarov
MTMaria A. Talyan
Maria A. Talyan
ГЭГоровая Софья Эдуардовна
Горовая Софья Эдуардовна
The Enhanced Recovery After Surgery (ERAS) concept is a comprehensive multidisciplinary approach based on scientific principles, aimed at optimizing patient management during the perioperative period. Despite the proven efficacy of ERAS across various oncological surgeries, the impact of this approach on perioperative outcomes in the treatment of prostate cancer remains underexplored. This review analyzes current scientific data on the application of ERAS principles in the preoperative, intraoperative, and postoperative stages of prostate cancer treatment. A literature search was conducted in the electronic databases PubMed and Google Scholar using the following keywords in Russian and English: концепция ускоренного восстановления после операции / enhanced recovery after surgery, радикальная простатэктомия / radical prostatectomy, роботическая радикальная простатэктомия / robotic radical prostatectomy, рак предстательной железы / prostate cancer, and eras. The search was performed in accordance with PRISMA guidelines. A total of 100 studies were included in the review. ERAS encompasses the entire perioperative period, from patient preparation to postoperative recovery. This enables effective implementation of radical prostatectomy and ensures high-quality rehabilitation. Currently, the combination of ERAS with robotic radical prostatectomy demonstrates advantages related to minimal invasiveness and high procedural reliability, which contribute to shorter operative times, reduced postoperative complications, accelerated patient’s recovery, and improved healthcare staff satisfaction. To fully assess the benefits of ERAS, it is essential to systematize existing concepts and recommendations in the field of surgical treatment of prostate cancer and to conduct high-quality multicenter studies aimed at exploring rehabilitation, complication prevention, and patient-reported outcomes. This will help expand the potential of ERAS and enhance its impact on treatment outcomes.